PGNY

Progyny, Inc. Common Stock

23.87

USD

PGNY Earnings Reports

Positive Surprise Ratio

PGNY beat 20 of 25 last estimates.

80%

Next Report

Date of Next Report

Feb 25, 2026

Estimate for Q4 25 (Revenue/ EPS)

$313.60M

$0.14

Implied change from Q3 25 (Revenue/ EPS)

+0.08%

-6.67%

Implied change from Q4 24 (Revenue/ EPS)

+5.08%

+16.67%

Progyny, Inc. Common Stock earnings per share and revenue

On Nov 06, 2025, PGNY reported earnings of 0.15 USD per share (EPS) for Q3 25, beating the estimate of 0.13 USD, resulting in a 14.24% surprise. Revenue reached 313.35 million, compared to an expected 305.24 million, with a 2.65% difference. The market reacted with a +24.21% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 13 analysts forecast an EPS of 0.14 USD, with revenue projected to reach 313.60 million USD, implying an decrease of -6.67% EPS, and increase of 0.08% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Danaher Corporation

Report Date

Jan 28, 2026 For Q4 25

Estimate

$2.17

Actual

$2.23

Surprise

+2.56%

HCA Healthcare, Inc.

Report Date

Jan 27, 2026 For Q4 25

Estimate

$7.53

Actual

$8.14

Surprise

+8.05%

Elevance Health, Inc.

Report Date

Jan 28, 2026 For Q4 25

Estimate

$3.12

Actual

$3.33

Surprise

+6.46%

FAQ

What were Progyny, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Progyny, Inc. Common Stock reported EPS of $0.15, beating estimates by 14.24%, and revenue of $313.35M, 2.65% above expectations.

How did the market react to Progyny, Inc. Common Stock's Q3 2025 earnings?

The stock price moved up 24.21%, changed from $18.01 before the earnings release to $22.37 the day after.

When is Progyny, Inc. Common Stock expected to report next?

The next earning report is scheduled for Feb 25, 2026.

What are the forecasts for Progyny, Inc. Common Stock's next earnings report?

Based on 13 analysts, Progyny, Inc. Common Stock is expected to report EPS of $0.14 and revenue of $313.60M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.